Answers are grounded in this paper and cite their sources.
diagnosed esophageal carcinoma have distant metastatic disease at presentation, in which the lung is the third most common site and accounts for 20% of metastasis cases [1] .The prognosis of these patients is extremely poor and the urgent establishment of effective treatment is essential.We here describe a successful treatment for esophageal carcinoma with lung metastasis by induction chemotherapy followed by salvage esophagectomy. CASE REPORTA 51-year-old man complained of dysphagia for over two months.Endoscopy and a computed tomography (CT) scan of the chest performed in an affiliated hospital showed a circumferential tumor in the middle thoracic esophagus with bilateral multiple pulmonary nodules.He was referred to our hospital for further examination and treatment, and admitted on May 24, 2000.On physical examination, lymph nodes were palpable in the left supraclavicular fossa.Laboratory data including tumor markers were all within normal limits.A chest X-ray showed multiple small nodules in the bilateral lung.A barium meal study revealed an ulcerative tumor, 20 cm in length, mainly located in the middle and lower thoracic esophagus extending to the upper thoracic esophagus (Figure 1A).Endoscopy disclosed a protruding tumor 25 cm distal from the dental arch followed by a circumferential ulcerative tumor between 30 cm and 38 cm distal from the dental arch.A biopsy specimen histologically proved that it was a moderately differentiated squamous cell carcinoma.A CT scan of the neck through the abdomen demonstrated bilateral supraclavicular lymph node swelling and a total of 8 small nodules in the bilateral lung up to 1 cm in size with clear boundary (Figure 2A).Based on these findings, he was diagnosed with unresectable thoracic esophageal carcinoma with metastases to non-regional lymph nodes and lung, classified as stage IVB according to the TNM classification of the International Union Against Cancer (UICC) [2] .With his written informed consent, he was registered with the Japan Clinical Oncology Group (JCOG) Trial (JCOG 9905), which was a phase II study of nedaplatin (NDP) and 5-fluorouracil (5-FU) in metastatic squamous cell carcinoma of the esophagus.Each course of chemotherapy consisted of 140 mg of NDP on d 1 and 1250 mg of 5-FU with continuous infusion on d 1-5.
No takes yet. Share an insight, caveat, or question.
S Kosugi (2006) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: